The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis
Guardado en:
Autores principales: | Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae3e09619da343589046f6d3dc822fa5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unsolved issues of The Efficacy and Safety of Edoxaban
por: Leszek Drabik, et al.
Publicado: (2021) -
Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado: (2021) -
Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Dong Lin, et al.
Publicado: (2021) -
Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020) -
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice
por: Eue-Keun Choi, et al.
Publicado: (2021)